National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

captopril
A sulfhydryl-containing analog of proline with antihypertensive activity and potential antineoplastic activity. Captopril competitively inhibits angiotensin converting enzyme (ACE), thereby decreasing levels of angiotensin II, increasing plasma renin activity, and decreasing aldosterone secretion. This agent may also inhibit tumor angiogenesis by inhibiting endothelial cell matrix metalloproteinases (MMPs) and endothelial cell migration. Captopril may also exhibit antineoplastic activity independent of effects on tumor angiogenesis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Capoten
Abbreviation:CPT
Chemical structure name:(S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline



Previous:canertinib dihydrochloride, cannabis-based oromucosal spray GW-1000-02, Canvaxin, capecitabine, Capoten
Next:caracemide, carbamazepine, carbogen, carbon-11 acetate, carboplatin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov